Related Experiment Video
Updated: Jul 11, 2026

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Lymphopenia in severe acute respiratory syndrome: a summary on its frequency
1Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. wviroj@yahoo.com
Abstract:
Severe acute respiratory syndrome (SARS) is a new human infectious disease caused by coronavirus. The first world outbreak occurs in 2002, starting from China and then thorough many countries. Abnormal hematological variables were common among patients with SARS. Concerning lymphocyte disorder, there were some previous studies reported the low lymphocyte in the patients with SARS. Here, the author performs a further analysis to document the frequency of the lymphopenia in SARS by the way of metanalysis study. Five available reports concerning the prevalence of lymphopenia in SARS among different populations were selected for further analysis in this study. Overall 637 SARS patients were retrospectively analyzed and 492 cases presented lymphopenia. According to this study, the overall prevalence rate of lymphopenia in SARS is 77.2 %. No significant correlation between the population ethnicity and the prevalence rate was detected in this study (P > 0.05). Here, the lymphopenia can be documented as an important characteristic of blood picture in the patients with SARS or it can indicate that "SARS is a viral-induced lymphopenia disease".
Related Concept Videos
Respiratory Syncytial Virus Disease
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-IV
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-III